- Sponsors conducting clinical trials require the collection of participant blood samples at specific intervals and over a rolling period, necessitating an experienced cell processing solutions provider in the regions the trials are conducted.
- CROs and clinical sites often lack the laboratory infrastructure and staff to support sample processing and cryopreservation capabilities, limiting clinical site selection for Sponsors.
- Extended transport times lead to process uncertainty, exacerbating risk for Sponsors.
- Sponsors typically de-risk their clinical trials by stringent supplier selection criteria, including:
- Maintain robust quality and process controls within the required processing times.
- Scale processing capacity to accommodate dynamic supply and demand schedules.
- Reduce risk via client-centric project management teams to actively manage complexities.
- OrganaBio established a novel bi-coastal Hub Processing Model – in Miami, FL and Irvine, California – to support clinical trials of two large cap, global pharmaceutical companies. View ISCT 2024 Poster.
![The Cell Preservation Society](https://www.organabio.com/wp-content/uploads/2024/08/The-Cell-Preservation-Society.png)